Ryan Fischer
Pediatric Transplant Hepatology · Kansas City, MONPI 1093981946
Payments from drug & device makers
Across 401 payments — averaging $1947.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Albireo Pharma, Inc.$498K
- Gilead$152K
- Mirum Pharmaceuticals, Inc.$85K
- Ipsen Biopharmaceuticals, Inc$47K
- Travere Therapeutics, Inc.$110
- Ipsen Pharma SAS$75
- plus $81 from 3 others
What the payments were for
- Consulting fees$64,20342%
- Speaking & faculty fees$65,15643%
- Travel & lodging$18,38712%
- Food & beverage$4,3283%
- Education$210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Albireo Pharma, Inc. | 164 | $497,541 |
| Gilead | 94 | $151,592 |
| Mirum Pharmaceuticals, Inc. | 102 | $84,839 |
| Ipsen Biopharmaceuticals, Inc | 30 | $46,551 |
| Travere Therapeutics, Inc. | 6 | $110 |
| Ipsen Pharma SAS | 1 | $75 |
| AstraZeneca | 2 | $31 |
| QOL Medical, LLC | 1 | $26 |
| Eton Pharmaceuticals, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few pediatric transplant hepatology providers in Missourito place this figure against a meaningful peer group, so we don't.
Other pediatric transplant hepatology in Kansas City
- Voytek SlowikKansas City$17K
- Jennifer HalmaKansas City$156
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.